Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
The caudate nucleus from examples of Alzheimer's disease (mean age 68, range 51-77 yr) had a mean wet weight and total protein content that were significantly lower than control. Biochemical markers of various specific nerve cells were determined. These are thought to reflect intrinsic choliner...
Autors principals: | Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
1984
|
Ítems similars
-
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
per: Bowen, D, et al.
Publicat: (1983) -
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
per: Wilcock, G, et al.
Publicat: (1983) -
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
per: Emma Barrett, et al.
Publicat: (2024-06-01) -
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
per: Hunter White, et al.
Publicat: (2022-11-01) -
Interpretive monitoring in the caudate nucleus
per: Marianna Yanike, et al.
Publicat: (2014-11-01)